Literature DB >> 14968949

Extracranial stereotactic radioablation: physical principles.

Lech Papiez1, Robert Timmerman, Colleen DesRosiers, Marcus Randall.   

Abstract

Extracranial stereotactic radioablation (ESR) involves treating well-demarcated targeted tissues (e.g. tumor with minimal margin for set-up uncertainties) with very large doses of radiation in single or a few fractions with the intent of causing profound late tissue damage within the targeted volume. In such circumstances, considerable effort must be taken to reduce non-target tissue exposure to the high dose levels in order to prevent late complications to involved organs. Consequently, the following conditions for effective delivery of the ESR techniques have to be satisfied: 1) delivery of a high dose per fraction, i.e. 10-24 Gy; 2) delivery of only a few fractions per course of treatment (e.g. 1-4); 3) shaping of the prescription isodose surface conformally to the target surface; 4) delivery of a non-uniform dose distribution within the target with the highest dose in centrally located regions of hypoxia; 5) rapid fall-off of dose from the target volume to healthy tissue in all directions. In this paper it is shown that high doses per fraction in few fractions can be delivered to a variety of locations with both efficacy and acceptable toxicity (conditions 1 and 2). Conformal shaping of the high isodose surfaces is best accomplished by employing many beams (5-10) each with carefully milled apertures precisely coincident with the target projection (condition 3). Beam intensity modulation creating parabolic beam entrance fluence profiles both concentrates the highest dose in central regions of tumor hypoxia and increases fall-off gradients outside of the target (conditions 4 and 5). It is also shown that isotropic, highly non-coplanar beam arrangements avoiding oppositional fields allow more optimal fall-off gradients to normal tissue as opposed to coplanar treatments (condition 5).

Entities:  

Mesh:

Year:  2003        PMID: 14968949     DOI: 10.1080/02841860310013490

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  20 in total

Review 1.  The emerging role of stereotactic radiotherapy in gastrointestinal malignancies: a review of the literature and analysis from the Irish perspective.

Authors:  Siobhra O'Sullivan; Daniel N Cagney
Journal:  Ir J Med Sci       Date:  2018-02-08       Impact factor: 1.568

2.  An orthotopic lung tumor model for image-guided microirradiation in rats.

Authors:  Debabrata Saha; Linda Watkins; Yi Yin; Philip Thorpe; Michael D Story; Kwang Song; Pavithra Raghavan; Robert Timmerman; Benjamin Chen; John D Minna; Timothy D Solberg
Journal:  Radiat Res       Date:  2010-07       Impact factor: 2.841

Review 3.  Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice.

Authors:  Robert D Timmerman; Joseph Herman; L Chinsoo Cho
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

4.  Dose escalation in extracranial stereotactic ablative radiotherapy (DESTROY-1): A multiarm Phase I trial.

Authors:  Francesco Deodato; Gabriella Macchia; Savino Cilla; Anna Ianiro; Giuseppina Sallustio; Silvia Cammelli; Milly Buwenge; Gian Carlo Mattiucci; Vincenzo Valentini; Alessio G Morganti
Journal:  Br J Radiol       Date:  2018-11-01       Impact factor: 3.039

5.  Implications of a high-definition multileaf collimator (HD-MLC) on treatment planning techniques for stereotactic body radiation therapy (SBRT): a planning study.

Authors:  James A Tanyi; Paige A Summers; Charles L McCracken; Yiyi Chen; Li-Chung Ku; Martin Fuss
Journal:  Radiat Oncol       Date:  2009-07-10       Impact factor: 3.481

6.  Clinical application of CyberKnife for high-risk central nervous system tumors: A clinical trial report of 60 cases.

Authors:  Xin Wang; Yuan-Yuan Wang; Peng Jiang; Jian-Jun Ma; Zhen Qu; Han-Chen Liu; Shan-Shan Wang; Yi-Shan Wang
Journal:  Exp Ther Med       Date:  2011-09-23       Impact factor: 2.447

7.  Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomes.

Authors:  Christopher L Hallemeier; Michael C Stauder; Robert C Miller; Yolanda I Garces; Robert L Foote; Jann N Sarkaria; Heather J Bauer; Charles S Mayo; Kenneth R Olivier
Journal:  J Radiosurg SBRT       Date:  2013

8.  CyberKnife for hilar lung tumors: report of clinical response and toxicity.

Authors:  Keith Unger; Andrew Ju; Eric Oermann; Simeng Suy; Xia Yu; Saloomeh Vahdat; Deepa Subramaniam; K William Harter; Sean P Collins; Anatoly Dritschilo; Eric Anderson; Brian T Collins
Journal:  J Hematol Oncol       Date:  2010-10-22       Impact factor: 17.388

9.  CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Stage I Non-Small Cell Lung Cancer.

Authors:  Viola J Chen; Eric Oermann; Saloomeh Vahdat; Jennifer Rabin; Simeng Suy; Xia Yu; Sean P Collins; Deepa Subramaniam; Filip Banovac; Eric Anderson; Brian T Collins
Journal:  Front Oncol       Date:  2012-02-01       Impact factor: 6.244

Review 10.  Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.

Authors:  Percy Lee; Billy W Loo; Tithi Biswas; George X Ding; Issam M El Naqa; Andrew Jackson; Feng-Ming Kong; Tamara LaCouture; Moyed Miften; Timothy Solberg; Wolfgang A Tome; An Tai; Ellen Yorke; X Allen Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-04-05       Impact factor: 8.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.